VahatiCor
PrivateLast Round
Series B
Nov 18, 2025
Total Funding Raised
$23M
Momentum Score
25 /100
Company Overview
VahatiCor is a medical technology company developing the A-FLUX Reducer System, an implantable device designed to treat Coronary Microvascular Dysfunction (CMD).
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VahatiCor Comps
Public and private peers based on sector, stage, and business model.
VahatiCor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 18, 2025 |
VahatiCor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| T45 Labs | Series B |
| Intuitive Ventures | Series B |
| S3 Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Grew 50% QoQ from 10 to 15 employees.
- Nov 18, 2025
$23M round completed.
VahatiCor Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VahatiCor's valuation, stock price, and market status.
